<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230208057352N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-02-20</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Effects of Transcranial Direct Current Stimulation (tDCS) in Males with Chronic Ankle Instability (CAI)</public_title>
      <acronym></acronym>
      <scientific_title>Effects of Transcranial Direct Current Stimulation (tDCS) on Clinical Symptoms and Neurocognitive Function in Males with Chronic Ankle Instability (CAI)</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-02-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>20</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/68468</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization will be done using Random Allocation Software and based on the random block method with a block size of 4 and with an allocation ratio of 1:1, Blinding description: This study is a single-blind study and in fact, the participants do not know which group they are in (experimental or control). Of course, before entering the study, the participants will be informed in a consent form that they may be placed in one of the two experimental or control groups, but they will not be informed of which group they will enter. The experimental group will receive real anodal tDCS and the control group will receive sham current, and in the sham group the current will be cut off without the knowledge of the participants after 30 seconds.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Chronic Ankle Instability.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In this group, anodal transcranial direct current stimulation (tDCS) and exercises are used. Sessions are held 3 days a week for 4 weeks (12 sessions in total) and the duration of each session is estimated to be around 40 minutes. tDCS is applied using the Neurostim2 device of Medinateb Gostar company. Electrodes are placed in a sponge soaked with sterile salt (%0.09 NaCl). The active electrode (anode) is placed on M1 on the opposite side of the involved leg (C3 in cases of right ankle involvement and C4 in cases of left ankle involvement, according to the International 10-20 system). We place the reference electrode (cathode) over the forehead area on the side of the involved wrist. Anodal current is applied with an intensity of 2 mA and for 20 minutes. At first, the current is gradually increased for 30 seconds (ramp up) until it reaches 2 milliamps. During the entire stimulation time, we monitor the person for safety. In the end, the current is reduced for 30 seconds (ramp down) until it reaches zero. After applying tDCS, participants will perform progressive strength and balance exercises. Strength exercises using Thera-band are performed in 4 directions: plantar flexion, dorsiflexion, inversion, and eversion. The movements should be performed in 3 sets with 10 reps in each direction. Every three sessions, the exercises will progress and the Thera-band with more resistance will be used. Single-leg stance exercises are performed in 3 repetitions and 2 positions with eyes open and closed. Each activity (eyes open and closed) has 7 levels of difficulty. The exercise will progress to the next level whenever the participant can do 3 repetitions without errors. Intervention 2: Control group: In the control group, the same exercises are performed as in the intervention group. Also, in this group, tDCS is used with the same electrode placement as the intervention group, but the current is only maintained for 30 seconds and then it stops (sham).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data is potentially shareable after de-identifying individuals

When:
Access period starts 3 months after the articles are published

To whom:
For researchers working in academic, scientific, and hospital institutions and clinicians

Conditions:
Researchers working in the field of neuroscience and rehabilitation of musculoskeletal disorders

Where to obtain:
Applicants for documentation can contact Sara Asadi Abadi via email.
s-asadiabadi@razi.tums.ac.ir

How to obtain:
After receiving the request and stating the reasons for the need for the data, the request will be answered within a maximum period of one month

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sara Asadi Abadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation, Piche-Shemiran, Enghelab Ave.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1148965111</zip>
        <telephone>00 21 77528468</telephone>
        <email>s-asadiabadi@razi.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Azadeh Shadmehr</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation, Piche-Shemiran, Enghelab Ave.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1148965111</zip>
        <telephone>+98 21 7752 8468</telephone>
        <email>Shadmehr@tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Males, 18-40 yrs; with a history of at least 1 significant ankle sprain (associated with pain, swelling, and/or dislocation) occurred at least 12 months prior to study enrollment
Participants should report at least 2 episodes of giving way in the 6 months prior to study enrollment
Cumberland Ankle Instability Tool (CAIT) score ≤ 24. Foot and Ankle Ability Measure (FAAM): ADL subscale &lt;90%, Sports subscale &lt;80%
No pain in involved ankle
Participants should be right-handed
Instability should be unilateral</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>40 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Neurologic or orthopedic disorders wich may cause balance impairments
History of lower extremity fracture or lower-extremity surgery
Uncorrected hearing or visual impairments
Have any metallic implants, pacemakers, intracranial electrodes, surgical clips
A history of migraines, seizure, or head injury resulting in a loss of consciousness
If contact with the scalp is not possible
Have a scalp or skin condition (e.g., psoriasis or eczema)
Using medications that may alter seizure threshold or cognitive performance
If participants consume alcohol or caffeine 12 hours before the sessions</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M24.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Instability secondary to old ligament injury</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In this group, anodal transcranial direct current stimulation (tDCS) and exercises are used. Sessions are held 3 days a week for 4 weeks (12 sessions in total) and the duration of each session is estimated to be around 40 minutes. tDCS is applied using the Neurostim2 device of Medinateb Gostar company. Electrodes are placed in a sponge soaked with sterile salt (%0.09 NaCl). The active electrode (anode) is placed on M1 on the opposite side of the involved leg (C3 in cases of right ankle involvement and C4 in cases of left ankle involvement, according to the International 10-20 system). We place the reference electrode (cathode) over the forehead area on the side of the involved wrist. Anodal current is applied with an intensity of 2 mA and for 20 minutes. At first, the current is gradually increased for 30 seconds (ramp up) until it reaches 2 milliamps. During the entire stimulation time, we monitor the person for safety. In the end, the current is reduced for 30 seconds (ramp down) until it reaches zero. After applying tDCS, participants will perform progressive strength and balance exercises. Strength exercises using Thera-band are performed in 4 directions: plantar flexion, dorsiflexion, inversion, and eversion. The movements should be performed in 3 sets with 10 reps in each direction. Every three sessions, the exercises will progress and the Thera-band with more resistance will be used. Single-leg stance exercises are performed in 3 repetitions and 2 positions with eyes open and closed. Each activity (eyes open and closed) has 7 levels of difficulty. The exercise will progress to the next level whenever the participant can do 3 repetitions without errors.</i_keyword>
      <i_keyword>Control group: In the control group, the same exercises are performed as in the intervention group. Also, in this group, tDCS is used with the same electrode placement as the intervention group, but the current is only maintained for 30 seconds and then it stops (sham)</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Visual choice reaction time. Timepoint: Before starting the intervention (the beginning of the first session) and after completion of 12 intervention sessions (the end of the last session). Method of measurement: Speed Anticipation Reaction Time Test (SART) software.</prim_outcome>
      <prim_outcome>Auditory choice reaction time. Timepoint: Before starting the intervention (the beginning of the first session) and after completion of 12 intervention sessions (the end of the last session). Method of measurement: SART software.</prim_outcome>
      <prim_outcome>Visual complex choice reaction time. Timepoint: Before starting the intervention (the beginning of the first session) and after completion of 12 intervention sessions (the end of the last session). Method of measurement: SART software.</prim_outcome>
      <prim_outcome>Auditory complex choice reaction time. Timepoint: Before starting the intervention (the beginning of the first session) and after completion of 12 intervention sessions (the end of the last session). Method of measurement: SART software.</prim_outcome>
      <prim_outcome>Low speed anticipation skill. Timepoint: Before starting the intervention (the beginning of the first session) and after completion of 12 intervention sessions (the end of the last session). Method of measurement: SART software.</prim_outcome>
      <prim_outcome>High speed anticipation skill. Timepoint: Before starting the intervention (the beginning of the first session) and after completion of 12 intervention sessions (the end of the last session). Method of measurement: SART software.</prim_outcome>
      <prim_outcome>Static balance: Foot-lift test. Timepoint: Before starting the intervention (the beginning of the first session) and after completion of 12 intervention sessions (the end of the last session). Method of measurement: Calculation of the average number of errors in three tests.</prim_outcome>
      <prim_outcome>Dynamic balance: Modified Star Excursion Balance Test. Timepoint: Before starting the intervention (the beginning of the first session) and after completion of 12 intervention sessions (the end of the last session). Method of measurement: Tape measure.</prim_outcome>
      <prim_outcome>Single-leg side-hop test. Timepoint: Before starting the intervention (the beginning of the first session) and after completion of 12 intervention sessions (the end of the last session). Method of measurement: Stopwatch.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The Cumberland Ankle Instability Tool's score. Timepoint: Before starting the intervention, after the completion of 12 intervention sessions (end of the last session). Method of measurement: The Cumberland Ankle Instability Tool.</sec_outcome>
      <sec_outcome>The Foot and Ankle Ability Measure questionnaire (FAAM) score. Timepoint: Before starting the intervention, after the completion of 12 intervention sessions (end of the last session). Method of measurement: The Foot and Ankle Ability Measure questionnaire (FAAM).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-02-06</approval_date>
        <contact_name>Research Ethics Committees of School of Nursing and Midwifery &amp; Rehabilitation - Tehran University o</contact_name>
        <contact_address>School of Rehabilitation of Tehran University of Medical Sciences, Piche-Shemiran, Enghelab Ave. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
